HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Abstract
Locally advanced rectal cancer is regularly treated with trimodality therapy consisting of neoadjuvant chemoradiation, surgery and adjuvant chemotherapy. There is a need for biomarkers to assess treatment response, and aid in stratification of patient risk to adapt and personalise components of the therapy. Currently, pathological stage and tumour regression grade are used to assess response. Experimental markers include proteins involved in cell proliferation, apoptosis, angiogenesis, the epithelial to mesenchymal transition and microsatellite instability. As yet, no single marker is sufficiently robust to have clinical utility. Microarrays that screen a tumour for multiple promising candidate markers, gene expression and microRNA profiling will likely have higher yield and it is expected that a combination or panel of markers would prove most useful. Moving forward, utilising serial samples of circulating tumour cells or circulating nucleic acids can potentially allow us to demonstrate tumour heterogeneity, document mutational changes and subsequently measure treatment response.
AuthorsS H Lim, W Chua, C Henderson, W Ng, J-S Shin, L Chantrill, R Asghari, C S Lee, K J Spring, P de Souza
JournalCritical reviews in oncology/hematology (Crit Rev Oncol Hematol) Vol. 96 Issue 1 Pg. 67-80 (Oct 2015) ISSN: 1879-0461 [Electronic] Netherlands
PMID26032919 (Publication Type: Journal Article, Review)
CopyrightCrown Copyright © 2015. Published by Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Biomarkers, Tumor
  • MicroRNAs
Topics
  • Biomarkers, Tumor (analysis)
  • Chemoradiotherapy
  • Epithelial-Mesenchymal Transition
  • Humans
  • MicroRNAs (analysis)
  • Microsatellite Instability
  • Neoadjuvant Therapy
  • Neoplastic Cells, Circulating
  • Prognosis
  • Rectal Neoplasms (genetics, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: